Alambic Investment Management’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-562	Closed	-$221K	–	410
2018 Q1	$221K	Buy	+562	New	+$221K	0.03%	406